h1

h2

h3

h4

h5
h6

001     849469
005     20250623140609.0
024 7 _ |2 ISSN
|a 0887-6924
024 7 _ |2 ISSN
|a 1476-5551
024 7 _ |2 WOS
|a WOS:000803301800001
024 7 _ |2 doi
|a 10.1038/s41375-022-01589-y
024 7 _ |2 pmid
|a pmid:35643868
024 7 _ |2 datacite_doi
|a 10.18154/RWTH-2022-06825
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85133871622
037 _ _ |a RWTH-2022-06825
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-82)IDM06025
|a Brümmendorf, Tim Henrik
|b 0
|e Corresponding author
|u rwth
245 _ _ |a Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
|h online, print
260 _ _ |a London
|b Springer Nature
|c 2022
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
536 _ _ |0 G:(DE-82)X021000-OA
|a OA - Open Access Publikation mit Unterstützung der Universitätsbibliothek der RWTH Aachen University (X021000-OA)
|c X021000-OA
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: publications.rwth-aachen.de
591 _ _ |a Canada
591 _ _ |a France
591 _ _ |a Germany
591 _ _ |a Italy
591 _ _ |a Mexico
591 _ _ |a Singapore
591 _ _ |a Spain
591 _ _ |a UK
591 _ _ |a USA
700 1 _ |0 0000-0002-8636-1071
|a Cortes, Jorge E.
|b 1
700 1 _ |a Milojkovic, Dragana
|b 2
700 1 _ |a Gambacorti-Passerini, Carlo
|b 3
700 1 _ |a Clark, Richard E.
|b 4
700 1 _ |a le Coutre, Philipp
|b 5
700 1 _ |a Garcia-Gutierrez, Valentin
|b 6
700 1 _ |a Chuah, Charles
|b 7
700 1 _ |0 0000-0002-5290-9289
|a Kota, Vamsi
|b 8
700 1 _ |a Lipton, Jeffrey H.
|b 9
700 1 _ |0 0000-0003-3238-4494
|a Rousselot, Philippe
|b 10
700 1 _ |0 0000-0002-2251-4032
|a Mauro, Michael J.
|b 11
700 1 _ |a Hochhaus, Andreas
|b 12
700 1 _ |a Hurtado Monroy, Rafael
|b 13
700 1 _ |a Leip, Eric
|b 14
700 1 _ |a Purcell, Simon
|b 15
700 1 _ |a Yver, Anne
|b 16
700 1 _ |a Viqueira, Andrea
|b 17
700 1 _ |a Deininger, Michael W.
|b 18
773 _ _ |0 PERI:(DE-600)2008023-2
|a 10.1038/s41375-022-01589-y
|n 7
|p 1825-1833
|t Leukemia : normal and malignant hemopoiesis
|v 36
|x 0887-6924
|y 2022
856 4 _ |u https://publications.rwth-aachen.de/record/849469/files/849469.pdf
|y OpenAccess
876 7 _ |c 1497.32
|d 2022-07-07
|e Hybrid-OA
|j DEAL
|v 272
|l SpringerNature
|x 021000-
909 C O |o oai:publications.rwth-aachen.de:849469
|p dnbdelivery
|p openCost
|p VDB
|p driver
|p OpenAPC_DEAL
|p open_access
|p openaire
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06025
|a RWTH Aachen
|b 0
|k RWTH
914 1 _ |y 2022
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b LEUKEMIA : 2019
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b LEUKEMIA : 2019
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2021-01-29
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2021-01-29
915 _ _ |0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
|a Creative Commons Attribution CC BY 4.0
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2021-01-29
915 p c |0 PC:(DE-HGF)0113
|2 APC
|a DEAL: Springer Nature 2020
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2
|l Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)
|x 0
980 1 _ |a FullTexts
980 _ _ |a APC
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21